IN8bio Inc (INAB)
1.01
+0.01
(+1.19%)
USD |
NASDAQ |
May 07, 12:26
IN8bio Total Assets (Quarterly): 33.71M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 33.71M |
| September 30, 2023 | 26.21M |
| June 30, 2023 | 29.72M |
| March 31, 2023 | 24.68M |
| December 31, 2022 | 33.04M |
| September 30, 2022 | 38.38M |
| June 30, 2022 | 30.99M |
| March 31, 2022 | 36.54M |
| Date | Value |
|---|---|
| December 31, 2021 | 42.22M |
| September 30, 2021 | 47.13M |
| June 30, 2021 | 17.56M |
| March 31, 2021 | 20.42M |
| December 31, 2020 | 20.91M |
| June 30, 2020 | 3.647M |
| December 31, 2019 | 1.13M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.13M
Minimum
Dec 2019
47.13M
Maximum
Sep 2021
27.09M
Average
29.72M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Jaguar Health Inc | 50.76M |
| Aptevo Therapeutics Inc | 24.84M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.772M |
| Shareholders Equity (Quarterly) | 24.94M |